Search research articles
Contact Us
Filters
Showing results (131-140 of 140) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 140 results.
Breast (Edinburgh, Scotland)
|
December 11, 2020
Impact of body mass index on overall survival in patients with metastatic breast cancer
Khalil Saleh, Matthieu Carton, Véronique Dieras, et al.
Nature Communications
|
July 14, 2023
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
Rania El-Botty, Ludivine Morriset, Elodie Montaudon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2022
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer
Thomas Bachelot, Paul Cottu, Sylvie Chabaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 6, 2024
Metabolomic Prediction of Breast Cancer Treatment-Induced Neurologic and Metabolic Toxicities
Max Piffoux, Jérémie Jacquemin, Mélanie Pétéra, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2019
Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort
David Pasquier, Amélie Darlix, Guillaume Louvel, et al.
JAMA Network Open
|
April 14, 2022
Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France
Cécile Charles, Aurélie Bardet, Alicia Larive, et al.
Molecular & Cellular Proteomics : MCP
|
May 21, 2023
Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers
Jozsef Lazar, Peter Antal-Szalmas, Istvan Kurucz, et al.
Nature Communications
|
August 15, 2020
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance
Elodie Montaudon, Joanna Nikitorowicz-Buniak, Laura Sourd, et al.
Bulletin Du Cancer
|
April 13, 2020
[COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la Femme (SIFEM), the Société Française de Chirurgie Oncologique (SFCO), the Société Française de Sénologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)]
Joseph Gligorov, Thomas Bachelot, Jean-Yves Pierga, et al.
Journal of the National Cancer Institute
|
April 17, 2018
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
François-Clément Bidard, Stefan Michiels, Sabine Riethdorf, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 140) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 140 results.
Breast (Edinburgh, Scotland)
|
December 11, 2020
Impact of body mass index on overall survival in patients with metastatic breast cancer
Khalil Saleh, Matthieu Carton, Véronique Dieras, et al.
Nature Communications
|
July 14, 2023
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
Rania El-Botty, Ludivine Morriset, Elodie Montaudon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2022
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer
Thomas Bachelot, Paul Cottu, Sylvie Chabaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 6, 2024
Metabolomic Prediction of Breast Cancer Treatment-Induced Neurologic and Metabolic Toxicities
Max Piffoux, Jérémie Jacquemin, Mélanie Pétéra, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2019
Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort
David Pasquier, Amélie Darlix, Guillaume Louvel, et al.
JAMA Network Open
|
April 14, 2022
Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France
Cécile Charles, Aurélie Bardet, Alicia Larive, et al.
Molecular & Cellular Proteomics : MCP
|
May 21, 2023
Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers
Jozsef Lazar, Peter Antal-Szalmas, Istvan Kurucz, et al.
Nature Communications
|
August 15, 2020
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance
Elodie Montaudon, Joanna Nikitorowicz-Buniak, Laura Sourd, et al.
Bulletin Du Cancer
|
April 13, 2020
[COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la Femme (SIFEM), the Société Française de Chirurgie Oncologique (SFCO), the Société Française de Sénologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)]
Joseph Gligorov, Thomas Bachelot, Jean-Yves Pierga, et al.
Journal of the National Cancer Institute
|
April 17, 2018
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
François-Clément Bidard, Stefan Michiels, Sabine Riethdorf, et al.
Page
of 14